BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 8161370)

  • 1. Pathophysiology of septic shock and implications for therapy.
    Barron RL
    Clin Pharm; 1993 Nov; 12(11):829-45. PubMed ID: 8161370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology of cardiovascular dysfunction in septic shock.
    Parker MM
    New Horiz; 1998 May; 6(2):130-8. PubMed ID: 9654320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sepsis--the Wayne State University Symposium--part III. Bacteremia and endotoxemia: a discussion of their roles in the pathophysiology of gram-negative sepsis.
    Sibbald WJ
    Heart Lung; 1976; 5(5):765-71. PubMed ID: 823128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sepsis and septic shock.
    Zanetti G; Baumgartner JD; Glauser MP
    Schweiz Med Wochenschr; 1997 Mar; 127(12):489-99. PubMed ID: 9106949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine defence in endotoxin shock (a review).
    Berczi I
    Acta Microbiol Hung; 1993; 40(4):265-302. PubMed ID: 7976206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology, pathophysiology and clinical presentation of gram-negative sepsis.
    Hazinski MF; Iberti TJ; MacIntyre NR; Parker MM; Tribett D; Prion S; Chmel H
    Am J Crit Care; 1993 May; 2(3):224-35; quiz 236-7. PubMed ID: 8364674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endotoxin, tumor necrosis factor, and related mediators: new approaches to shock.
    Beutler B
    New Horiz; 1993 Feb; 1(1):3-12. PubMed ID: 7922391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Septic shock; current pathogenetic concepts from a clinical perspective.
    Tsiotou AG; Sakorafas GH; Anagnostopoulos G; Bramis J
    Med Sci Monit; 2005 Mar; 11(3):RA76-85. PubMed ID: 15735579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock.
    Ohlsson K; Björk P; Bergenfeldt M; Hageman R; Thompson RC
    Nature; 1990 Dec; 348(6301):550-2. PubMed ID: 2147233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basic therapeutic requirements in the treatment of sepsis in acute renal failure.
    Cambi V; David S
    Nephrol Dial Transplant; 1994; 9 Suppl 4():183-6. PubMed ID: 7800255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endotoxin as a therapeutic target in septic shock.
    Corriveau CC; Danner RL
    Infect Agents Dis; 1993 Feb; 2(1):35-43. PubMed ID: 8162352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current understanding of the pathogenesis of gram-negative shock.
    Waage A; Brandtzaeg P; Espevik T; Halstensen A
    Infect Dis Clin North Am; 1991 Dec; 5(4):781-91. PubMed ID: 1783767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology and treatment of gram-negative sepsis.
    DiPiro JT
    Am J Hosp Pharm; 1990 Nov; 47(11 Suppl 3):S6-10. PubMed ID: 2275478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current prospects for the treatment of clinical sepsis.
    Suffredini AF
    Crit Care Med; 1994 Jul; 22(7):S12-8. PubMed ID: 8026188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell therapy with a tissue-engineered kidney reduces the multiple-organ consequences of septic shock.
    Humes HD; Buffington DA; Lou L; Abrishami S; Wang M; Xia J; Fissell WH
    Crit Care Med; 2003 Oct; 31(10):2421-8. PubMed ID: 14530746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytokines and antagonists in septic shock].
    Girardin E; Dayer JM
    Schweiz Med Wochenschr; 1993 Mar; 123(11):480-91. PubMed ID: 8386392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiendotoxin therapies for septic shock.
    Corriveau CC; Danner RL
    Infect Agents Dis; 1993 Feb; 2(1):44-52. PubMed ID: 8162353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenic effects of endotoxin.
    Zivot JB; Hoffman WD
    New Horiz; 1995 May; 3(2):267-75. PubMed ID: 7583168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional modification of vascular endothelial cells by cytokines during septic shock.
    Endo S; Inada K; Yamada Y; Takakuwa T; Nakae H; Kasai T; Koike S; Inoue Y; Niimi M; Wakabayashi G; Taniguchi S
    Res Commun Mol Pathol Pharmacol; 1996 Oct; 94(1):23-38. PubMed ID: 8948012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current concepts in the pathogenesis and treatment of abortion and septic shock. II. The physiopathological bases and outlook in the management of septic shock].
    Figueroa Damian R; Arredondo García JL
    Ginecol Obstet Mex; 1993 Dec; 61():337-43. PubMed ID: 8119603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.